NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/28/2025
Back to search
Official data from USPTO
NORTHWEST BIOTHERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NORTHWEST BIOTHERAPEUTICS
ST13
US500000076325495Class
5
Filing
76325495
Registration
2882249
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
08/19/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/15/2001
Registration date
09/07/2004
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/21/1996
First use in commerce
07/06/1998
Drawing code
1
Owner type
03
Owner location
Bethesda, MD
Examiner
MCMORROW, RONALD
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc.
Representatives
Melissa A. Nowak Christensen O'Connor Johnson Kindness
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of cancer
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/28/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
03/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/07/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/18/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/18/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/18/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/18/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
09/05/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/29/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/16/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/14/2010
E815
TEAS SECTION 8 & 15 RECEIVED
08/31/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
09/07/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/22/2004
DOCK
ASSIGNED TO EXAMINER
06/22/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/21/2004
CFIT
CASE FILE IN TICRS
06/08/2004
PAPER RECEIVED
05/14/2004
IUAF
USE AMENDMENT FILED
05/11/2004
DOCK
ASSIGNED TO EXAMINER
04/26/2004
EX2G
SOU EXTENSION 2 GRANTED
12/15/2003
PAPER RECEIVED
11/17/2003
EXT2
SOU EXTENSION 2 FILED
11/11/2003
EX1G
SOU EXTENSION 1 GRANTED
06/16/2003
EXT1
SOU EXTENSION 1 FILED
05/02/2003
PAPER RECEIVED
05/02/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/12/2002
PUBO
PUBLISHED FOR OPPOSITION
08/20/2002
NPUB
NOTICE OF PUBLICATION
07/31/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2002
CNRT
NON-FINAL ACTION MAILED
12/27/2001
DOCK
ASSIGNED TO EXAMINER
12/14/2001
Continuous trademark protection
Get notified about every new filing that threatens NORTHWEST BIOTHERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.